Normobaric Oxygen Therapy in Acute Ischemic Stroke Trial
Status:
Terminated
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and efficacy of treating individuals with
acute ischemic stroke with normobaric oxygen therapy (NBO, given within 9 hours of symptom
onset), to standard medical treatment.
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)